Norbert W. Bischofberger

Director, President & Chief Executive Officer at Kronos Bio, Inc.

Norbert W. Bischofberger

Norbert W. Bischofberger

Director, President & Chief Executive Officer at Kronos Bio, Inc.

Overview
Career Highlights

Kronos Bio, Inc.

RelSci Relationships

1476

Number of Boards

7

Birthday

01/10/1956 - Austria

Age

65

Relationships
RelSci Relationships are individuals Norbert W. Bischofberger likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at VV Manager LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Incarda Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Omega Fund Management LLC

Relationship likelihood: Strong

Co-Founder at Kirax Corporation

Relationship likelihood: Strong

Co-Founder & Executive Chairman at Incarda Therapeutics, Inc.

Relationship likelihood: Strong

Executive Chairman & Founder at Amygdala Neurosciences, Inc.

Relationship likelihood: Strong

Independent Chairman of the Supervisory Board at Deutsche Bank AG

Relationship likelihood: Strong

President at Helmholtz-Gemeinschaft Deutscher Forschungszentren eV

Relationship likelihood: Strong

Professional at Bayer AG

Relationship likelihood: Strong

Professional at Bayer AG

Relationship likelihood: Strong

Paths to Norbert W. Bischofberger
Potential Connections via
Relationship Science
You
Norbert W. Bischofberger
Director, President & Chief Executive Officer at Kronos Bio, Inc.
Education
PhD in Organic Chemistry
Class of 1983

ETH Zurich is an engineering, science, technology, mathematics, and management university. It is an integral part of the Swiss Federal Institutes of Technology Domain (ETH Domain) that is directly subordinate to Switzerland's Federal Department of Economic Affairs, Education, and Research. ETH Zurich is consistently rated among the top universities in the world. It is considered the best university in continental Europe by the Shanghai Ranking ARWU, the Times Higher Education World University Rankings, and the QS World University Ranking. It is currently ranked 4th in Europe overall, and 8th best university in the world in engineering, science, and technology. Twenty-one Nobel Prizes have been awarded to students and professors of the institute in the past. The most famous of them is Albert Einstein in 1921 and the most recent is Richard F. Heck in 2010. It is a founding member of the IDEA League and the International Alliance of Research Universities (IARU); and a member of the CESAER network. ETH Zurich was founded by the Swiss Federal Government in 1854 with the stated mission to educate engineers and scientists, serve as a national center of excellence in science and technology, and provide a hub for interaction between the scientific community and industry.

Bachelor of Science in Chemistry
Class of 1980

The University of Innsbruck is a public university in Innsbruck, the capital of the Austrian federal state of Tyrol, founded in 1669.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Director, President & Chief Executive Officer
2018 - Current

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic malignancies, prostate cancer, MYC-driven cancers, and small cell/neuroendocrine cancers. The company was founded by Angela Koehler and Joshua A. Kazam in 2017 and is headquartered in San Mateo, CA.

Chief Scientific Officer & Executive Vice President-Research
1990 - 2018

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Manager-DNA Synthesis Group
1986 - 1990

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $2,499
2019

The California State Parks Foundation (CSPF) was founded in 1969 by William Penn Mott, Jr., former director of both California's Department of Parks and Recreation and the National Park Service. With our 130,000 members, CSPF is the only statewide independent nonprofit organization dedicated to protecting, enhancing and advocating for California's magnificent state parks. Since 1969, CSPF has raised more than $223 million to benefit state parks. CSPF is committed to improving the quality of life for all Californians by expanding access to the natural beauty, rich culture and history, and recreational and educational opportunities offered by California's 280 state parks—the largest state parks system in the United States.

$1,000 - $2,499
2018

The California State Parks Foundation (CSPF) was founded in 1969 by William Penn Mott, Jr., former director of both California's Department of Parks and Recreation and the National Park Service. With our 130,000 members, CSPF is the only statewide independent nonprofit organization dedicated to protecting, enhancing and advocating for California's magnificent state parks. Since 1969, CSPF has raised more than $223 million to benefit state parks. CSPF is committed to improving the quality of life for all Californians by expanding access to the natural beauty, rich culture and history, and recreational and educational opportunities offered by California's 280 state parks—the largest state parks system in the United States.

$1,000 - $2,499
2018

The San Francisco Aids Foundation is a private company headquartered in San Francisco, CA. The firm provides education, advocacy and direct services for HIV prevention and care.The company says this about itself: No city experienced epidemic levels of HIV faster than San Francisco. San Francisco AIDS Foundation works to end the epidemic where it first took hold, and eventually everywhere. Established in 1982, our mission is to radically reduce new infections in San Francisco. Through education, advocacy, and direct services for prevention and care, we are confronting HIV in communities most vulnerable to the disease.

Political Donations
$2,100
2006

Chairman at Fallen Journalists Memorial Foundation

Transactions
Details Hidden

Kronos Bio, Inc. raised money in a private placement transaction

Details Hidden

Kronos Bio, Inc. raised money in a private placement transaction

Investments
Details Hidden

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic malignancies, prostate cancer, MYC-driven cancers, and small cell/neuroendocrine cancers. The company was founded by Angela Koehler and Joshua A. Kazam in 2017 and is headquartered in San Mateo, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Norbert W. Bischofberger. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Norbert W. Bischofberger's profile does not indicate a business or promotional relationship of any kind between RelSci and Norbert W. Bischofberger.